SMS Lifesciences India Limited
Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates
What SMS files
- Others30
- Important30
- Board Meeting6
- Dividend/Bonus2
- Updates2
- Credit Ratings1
Haleos Labs Limited (formerly SMS Lifesciences) has declared a ₹1.50 per share (15%) dividend for FY24-25. Payment is temporarily withheld for shareholders needing to update KYC or correct bank details. Update your information to receive the dividend.
Haleos Labs updated on its physical share transfer re-lodgment window. The company confirmed no requests were received, processed, approved, or rejected under this active opportunity for shareholders.
Haleos Labs opened a special window for physical share transfer re-lodgments, communicated via web/print. To date, zero requests have been received or processed. The 6-month window remains active for investors.
SMS Lifesciences India Limited's name has changed to Haleos Labs Limited. Concurrently, Mr. Venkata Praveen Talluri was reappointed as Managing Director of material subsidiary, Mahi Drugs Private Limited, for three years.
SMS Lifesciences (soon to be Haleos Labs) has successfully cleared an audit by Brazil's health authority, ANVISA, for its API manufacturing facility (Unit-1). This regulatory win means their plant meets international quality standards, opening the door for the company to enter Brazil, South America's largest pharmaceutical market. This move could...